Top 5 Articles From September 2019
Dr. Katsanos’s thoughts regarding the vascular community’s reaction to his group’s meta-analysis, the potential influence of follow-up and adjudication variables, non-SFA applications, and what comes next.
With Konstantinos Katsanos, MSc, MD, PhD, EBIR
By Sabine Steiner, MD; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD
With Gary M. Ansel, MD; Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Marianne Brodmann, MD; Koen Deloose, MD; Andrew Holden, MBChB, FRANZCR, EBIR; John H. Rundback, MD; and Peter A. Schneider, MD
Key questions to consider for accurate diagnoses and tailored treatment decisions.
By Koen Deloose, MD
Experts discuss considerations in trial design, adjudication, and paths forward.
With Marianne Brodmann, MD; William Gray, MD; Peter A. Schneider, MD; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Thomas Zeller, MD, PhD
Top 5 from CIToday's Current Issue
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
By Joel Sauer, MBA
By Moderator: Matias Sztejfman, MD
Panelists: Guilherme Attizzani, MD; Cristian Baeza, MD; Hemal Gada, MD, MBA; Anthony Main, MD; and Henrique Barbosa Ribeiro, MD, PhD
By Moderator: Mirvat Alasnag, MD, FACP, FSCAI, FRCP
Panelists: James Nolan, MBChB, FRCP, MD; Sunil Rao, MD; and Binita Shah, MD, MS, FACC, FSCAI